AcoArt I now is available with 5 year data
On June 11, Prof. Dierk Scheinert presented on behalf of the principal investigator, Prof. Guo Wei, the latest 5 year safety and efficacy data from the randomized AcoArt I study, the first RCT study investgates DCB in treating SFA lesions in China.